Showing results (301-310 of 426) with videos related to

Sort By:
Pageof 43
Frontiers in Oncology|March 3, 2023
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitorsY Linda Wu, Grace van Hyfte, Umut Özbek, et al.
Psychiatry Research. Neuroimaging|January 22, 2026
Impact of genetic variants on hippocampal volume among individuals with schizophrenia and bipolar disordersTommaso Toffanin, Giulia Ida Perini, Halima Follador, et al.
Chemotherapy|April 28, 2024
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour BurdenJames Alexander Korolewicz, Bernhard Scheiner, Claudia A M Fulgenzi, et al.
Frontiers in Immunology|January 5, 2023
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort studyMattia Bellan, Daria Apostolo, Alice Albè, et al.
European Journal of Human Genetics : EJHG|August 21, 2014
Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndromeAlma Kuechler, Alexander M Zink, Thomas Wieland, et al.
Journal for Immunotherapy of Cancer|September 2, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international studyPetros Fessas, Ahmed Kaseb, Yinghong Wang, et al.
Journal for Immunotherapy of Cancer|September 14, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinomaTim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, et al.
JHEP Reports : Innovation in Hepatology|June 5, 2023
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinomaDavid J Pinato, Takahiro Kaneko, Antonio D'Alessio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line ChemotherapyMichele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
Pageof 43